Affordable Access

Neoadjuvant chemotherapy versus none for resectable gastric cancer.

Authors
  • Wu, A W
  • Xu, G W
  • Wang, H Y
  • Ji, J F
  • Tang, J L
Type
Published Article
Journal
The Cochrane database of systematic reviews
Publication Date
Jan 01, 2007
Issue
2
Identifiers
PMID: 17443566
Source
Medline
License
Unknown

Abstract

There is no definite evidence of the effectiveness of NAC in resectable gastric cancer, in terms of improvements in patient survival, in the trials we reviewed. Neoadjuvant chemotherapy should not be used routinely in clinical setting until further results from randomized clinical are available. Neoadjuvant chemotherapy of gastric cancer should be applied under the framework of clinical trials.

Report this publication

Statistics

Seen <100 times